Michael Smith is a Cardiology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3345 Plaza 10 Dr
E
Beaumont, TX 777072554
Telephone
409-838-2626Provider last certified this registry record 30 Sept 2022.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20255 payments
- E.R. Squibb & Sons, L.L.C.Program year20257 payments
- Cleerly, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.2%Beta blocker26.2%Carvedilol31%Metoprolol Succinate29%Labetalol Hcl15%Metoprolol Tartrate13%Sotalol5%Atenolol3%Acebutolol Hcl2%Bisoprolol Fumarate1%Part D<11 patientsCalcium channel blocker9.8%Amlodipine Besylate46%Diltiazem 24hr Er (Cd)21%Nifedipine Er16%Diltiazem Hcl7%Amlodipine Besylate-Benazepril4%Dilt-Xr3%Verapamil Er3%Part D<11 patients+ 17 more classes in this area
Blood & clotting
22.2%Factor Xa inhibitor16.9%Eliquis84%Xarelto16%Part D≥145 patientsP2Y12 inhibitor3.7%Clopidogrel100%Part D≥56 patients+ 2 more classes in this area
Metabolism & gastrointestinal
0.9%Proton pump inhibitor0.4%Pantoprazole Sodium100%Part D<11 patientsPotassium supplement0.3%Potassium Chloride100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 1989–2009 per NIH RePORTER. The latest:
- Mechanisms of Osteopathic Manipulative Medicine (OMM)
University of North Texas Hlth Sci Ctr
FY2009$347,420U19AT002023 - Mechanisms of Osteopathic Manipulative Medicine (OMM)
University of North Texas Hlth Sci Ctr
FY2008$770,624U19AT002023 - Sleep disordered breathing (SDB): Physiologic and healthcare disparities
University of North Texas Hlth Sci Ctr
FY2008$354,289P20MD001633
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”